Biotech Process Improvement Scaling 
Harvard Business Review
OCTOBER 23, 2018
While America has continued leading the world in terms of investment in basic science research, it has lost the ability to do the kinds of process improvements that are essential for innovation. Invest in hardware startups and scale-ups. ” But it should be possible for the United States to reverse these developments.
Kotter Inc.
OCTOBER 20, 2022
The COVID-19 pandemic created significant supply chain challenges as manufacturers and distribution channels shut down, pivoted, or significantly scaled back to fight the spread of the virus. Both Anders and Chris have life-long careers in the Pharma industry, holding senior roles in both Big Pharma and smaller biotech companies.
Expert insights. Personalized for you.
14 
Let's personalize your content